Ratings Johnson Health Tech .Co., Ltd.

Equities

1736

TW0001736007

End-of-day quote Taiwan S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
80.6 ^TWD	+2.54%		+4.81%	+17.32%

Mar. 15	Johnson Health Tech .Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 05	BowFlex files for bankruptcy with $37.5 million buyout offer	RE

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

The earnings growth currently anticipated by analysts for the coming years is particularly strong.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
Low profitability weakens the company.
With a 2024 P/E ratio at 23.71 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Over the past four months, analysts' average price target has been revised downwards significantly.
The average consensus view of analysts covering the stock has deteriorated over the past four months.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Recreational Products

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
JOHNSON HEALTH TECH .CO., LTD.	+17.32%	729M		-
AMER SPORTS OYJ	+4.27%	5.09B	-	-
FLUIDRA, S.A.	+4.30%	4.14B		B+
ACUSHNET HOLDINGS CORP.	-2.53%	4B		B-
TOPGOLF CALLAWAY BRANDS CORP.	+9.62%	2.98B		B+
TECHNOGYM S.P.A.	-2.92%	1.88B		B+
MIZUNO CORPORATION	+87.02%	1.21B		-
PELOTON INTERACTIVE, INC.	-50.25%	1.12B		D
FENIX OUTDOOR INTERNATIONAL AG	-10.08%	858M		B-
STURM, RUGER & COMPANY, INC.	+1.72%	808M	-	C

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes